Consolidated Biosciences ApS: Financial statements 2022
CVR: 40180230
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Consolidated Biosciences ApS (CVR 40180230) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -45,625 and a net result of DKK -1,002,210 compared with DKK -1,086,215 the year before. Equity in the 2022 report amounted to DKK 2,976,995. The solvency ratio was 4.1%.
- Gross Profit
- DKK -45,625
- Profit/Loss
- DKK -1,002,210
- Equity
- DKK 2,976,995
- Total Assets
- DKK 71,821,720
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -46K | -1M | 3M | - |
| 2021 | - | -34K | -1.1M | -1M | - |
| 2020 | - | -43K | -585K | 65K | - |
| 2019 | - | -25K | -430K | 50K | - |
Official annual report
Keep an eye on Consolidated Biosciences ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Consolidated Biosciences ApS has published its annual report for 2021. Gross profit came to DKK -33,750, and the net result was DKK -1,086,215.
About Consolidated Biosciences ApS
Consolidated Biosciences ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Lone Schøtt Kunøe. The company is owned by CENTRAL EUROPEAN FOOD PRODUCTION COMPANY ApS, CONSOLIDATED HOLDINGS A/S and L1 HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,501 and a net result of DKK -1,814,488 compared with DKK -1,740,301 the year before. Equity in the 2025 report amounted to DKK 202,862.